major depressive disorder

Nasal Spray, major depressive disorder

Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression

Fact checked by Nick Blackmer The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Interesting Engineering on MSN · 7d

US approves first nasal spray for major depressive disorder, PTSD conditions

Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of major depressive disorder (MDD),

WebMD · 3d

What to Know About the New Nasal Spray for Tough Depression

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more medication.

Medical News Today · 3d

FDA-approved nasal spray for severe depression can lead to remission

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.

Too Old to Operate1d

Risks of AEs With Mirtazapine in Major Depressive Disorder

The following is a summary of “Risks of adverse events with mirtazapine for adults with major depressive disorder: a ...

8don MSN

Using machine learning to predict how people diagnosed with major depressive disorder respond to treatment

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

New Atlas1d

A compelling new study is building on a growing body of evidence showing a common exercise supplement used to build muscle ...

14hon MSN

MindMed launches phase 3 trial for anxiety treatment

The MM120 ODT Phase 3 clinical development program also includes the Voyage study for GAD and the Emerge study for major depressive disorder (MDD). The U.S. Food and Drug Administration has granted ...

psychiatryadvisor.com1d

Preventive Interventions Effective for Subthreshold Depressive Symptoms

(HealthDay News) — Preventive psychological interventions may be effective for adults with subthreshold depressive symptoms, according to a review published online in the December issue of The Lancet ...

WebMD9d

Living With Major Depressive Disorder

I’ve been living with depression for almost 12 years. I’m 31 now and I found out I had major depressive disorder when I was 19. I had a miserable freshman year of college, but I didn't really ...

EurekAlert!3d

A new global study aims to map the brain signatures of bipolar disorder to transform understanding of the disease

A new study, led by USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI), will explore structural ...

Pharmabiz1d

Neurocrine Biosciences begins phase 3 registrational study of osavampator as an adjunctive therapy to treat major depressive disorder

Neurocrine Biosciences begins phase 3 registrational study of osavampator as an adjunctive therapy to treat major depressive disorder: San Diego Wednesday, January 29, 2025, 18:00 ...

Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights

Neurocrine Biosciences advances Phase 3 plans for osavampator after achieving Phase 2 success in major depressive disorder, amending its Takeda deal.

Neurocrine Amends Agreement With Takeda for Major Depressive Disorder Treatment

Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder.

BioSpace2d

Neurocine Gains ‘High-Risk/High-Reward’ Depression Asset From Takeda

Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Nasal Spray, major depressive disorder

Related topics